Caitong International Asset Management Co., LTD Theravance Biopharma, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 258 shares of TBPH stock, worth $2,358. This represents 0.0% of its overall portfolio holdings.
Number of Shares
258Holding current value
$2,358% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TBPH
# of Institutions
137Shares Held
47.2MCall Options Held
700Put Options Held
1.4K-
Madison Avenue Partners, LP New York, NY9.51MShares$86.9 Million10.97% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$68.2 Million1.9% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$43.5 Million8.37% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$34.6 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$25.2 Million3.74% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $610M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...